View in EDS HTML Full Text PDF Full Text

Improved HbA1c and Body Weight in GADA-Positive Individuals Treated With Tirzepatide: A Post Hoc Analysis of SURPASS.

Saved in:
Bibliographic Details
Title: Improved HbA1c and Body Weight in GADA-Positive Individuals Treated With Tirzepatide: A Post Hoc Analysis of SURPASS.
Authors: Peters AL; University of Southern California Clinical Diabetes Program, Keck School of Medicine of the University of Southern California, Los Angeles, Los Angeles, CA 90033, USA., Buzzetti R; Department of Experimental Medicine, Sapienza University of Rome, Rome 00160, Italy., Lee CJ; Eli Lilly and Company, Indianapolis, IN 46285, USA., Pavo I; Eli Lilly and Company, Indianapolis, IN 46285, USA., Liu M; Tigermed-BCM Inc, Somerset, NJ 08873, USA., Karanikas CA; Eli Lilly and Company, Indianapolis, IN 46285, USA., Paik JS; Eli Lilly and Company, Indianapolis, IN 46285, USA.
Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2025 Mar 17; Vol. 110 (4), pp. e962-e969.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38824910
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Improved HbA1c and Body Weight in GADA-Positive Individuals Treated With Tirzepatide: A Post Hoc Analysis of SURPASS.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Peters+AL%22">Peters AL</searchLink>; University of Southern California Clinical Diabetes Program, Keck School of Medicine of the University of Southern California, Los Angeles, Los Angeles, CA 90033, USA.<br /><searchLink fieldCode="AU" term="%22Buzzetti+R%22">Buzzetti R</searchLink>; Department of Experimental Medicine, Sapienza University of Rome, Rome 00160, Italy.<br /><searchLink fieldCode="AU" term="%22Lee+CJ%22">Lee CJ</searchLink>; Eli Lilly and Company, Indianapolis, IN 46285, USA.<br /><searchLink fieldCode="AU" term="%22Pavo+I%22">Pavo I</searchLink>; Eli Lilly and Company, Indianapolis, IN 46285, USA.<br /><searchLink fieldCode="AU" term="%22Liu+M%22">Liu M</searchLink>; Tigermed-BCM Inc, Somerset, NJ 08873, USA.<br /><searchLink fieldCode="AU" term="%22Karanikas+CA%22">Karanikas CA</searchLink>; Eli Lilly and Company, Indianapolis, IN 46285, USA.<br /><searchLink fieldCode="AU" term="%22Paik+JS%22">Paik JS</searchLink>; Eli Lilly and Company, Indianapolis, IN 46285, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220375362%22">The Journal of clinical endocrinology and metabolism</searchLink> [J Clin Endocrinol Metab] 2025 Mar 17; Vol. 110 (4), pp. e962-e969.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0375362 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1945-7197 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220021972X%22">0021972X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Endocrinol Metab <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38824910
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1210/clinem/dgae372
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e962
    Titles:
      – TitleFull: Improved HbA1c and Body Weight in GADA-Positive Individuals Treated With Tirzepatide: A Post Hoc Analysis of SURPASS.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Peters AL
      – PersonEntity:
          Name:
            NameFull: Buzzetti R
      – PersonEntity:
          Name:
            NameFull: Lee CJ
      – PersonEntity:
          Name:
            NameFull: Pavo I
      – PersonEntity:
          Name:
            NameFull: Liu M
      – PersonEntity:
          Name:
            NameFull: Karanikas CA
      – PersonEntity:
          Name:
            NameFull: Paik JS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 03
              Text: 2025 Mar 17
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1945-7197
          Numbering:
            – Type: volume
              Value: 110
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: The Journal of clinical endocrinology and metabolism
              Type: main
ResultId 1